Parallel Advisors LLC increased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 259.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,911 shares of the pharmacy operator’s stock after purchasing an additional 3,546 shares during the quarter. Parallel Advisors LLC’s holdings in Walgreens Boots Alliance were worth $272,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. NEXT Financial Group Inc raised its holdings in shares of Walgreens Boots Alliance by 27.8% during the second quarter. NEXT Financial Group Inc now owns 2,663 shares of the pharmacy operator’s stock valued at $145,000 after acquiring an additional 580 shares during the period. First National Bank of South Miami raised its holdings in shares of Walgreens Boots Alliance by 3.0% during the second quarter. First National Bank of South Miami now owns 10,386 shares of the pharmacy operator’s stock valued at $566,000 after acquiring an additional 303 shares during the period. Synovus Financial Corp raised its holdings in shares of Walgreens Boots Alliance by 3.6% during the second quarter. Synovus Financial Corp now owns 16,177 shares of the pharmacy operator’s stock valued at $883,000 after acquiring an additional 555 shares during the period. H D Vest Advisory Services acquired a new stake in shares of Walgreens Boots Alliance during the second quarter valued at approximately $236,000. Finally, Cornerstone Advisors Inc. raised its holdings in shares of Walgreens Boots Alliance by 131.6% during the second quarter. Cornerstone Advisors Inc. now owns 894 shares of the pharmacy operator’s stock valued at $49,000 after acquiring an additional 508 shares during the period. Institutional investors and hedge funds own 60.60% of the company’s stock.
WBA has been the topic of a number of recent analyst reports. Cleveland Research restated a “hold” rating on shares of Walgreens Boots Alliance in a report on Monday, September 9th. Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research report on Friday, August 23rd. JPMorgan Chase & Co. downgraded shares of Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $73.00 to $63.00 in a research report on Wednesday, October 23rd. ValuEngine raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, October 30th. Finally, Pivotal Research lowered their price objective on shares of Walgreens Boots Alliance from $60.00 to $55.00 and set a “hold” rating on the stock in a research report on Wednesday, October 30th. Five equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $61.35.
Shares of NASDAQ WBA traded up $0.57 during trading hours on Friday, hitting $59.24. 5,450,000 shares of the stock were exchanged, compared to its average volume of 5,855,335. The firm has a market capitalization of $54.63 billion, a P/E ratio of 9.89, a P/E/G ratio of 1.53 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.73 and a quick ratio of 0.36. The company’s 50 day moving average is $55.10 and its 200 day moving average is $53.53. Walgreens Boots Alliance Inc has a one year low of $49.03 and a one year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Monday, October 28th. The pharmacy operator reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. Walgreens Boots Alliance had a net margin of 2.91% and a return on equity of 21.99%. The business had revenue of $33.95 billion during the quarter, compared to analysts’ expectations of $33.88 billion. During the same quarter last year, the company posted $1.48 EPS. The firm’s revenue for the quarter was up 1.5% on a year-over-year basis. Research analysts anticipate that Walgreens Boots Alliance Inc will post 5.93 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.458 per share. This represents a $1.83 dividend on an annualized basis and a yield of 3.09%. The ex-dividend date of this dividend is Friday, November 15th. Walgreens Boots Alliance’s dividend payout ratio is currently 30.55%.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the sale, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at approximately $18,064,318.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 15.73% of the stock is owned by corporate insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: How is an ETF different from a mutual fund?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.